Impact of the implementation of standardised early identification and diagnosis of transthyretin amyloidosis in high-risk patients: protocol of a high-quality diagnostic study (HI-QUAL ATTR)
10 May 2026 (08:30 - 09:15)
Organised by: 
Abstract
Slides
About the speaker
Zhongshan Hospital, Shanghai (China)
5 More presentations in this session
Doctor C. Goena Vives (Donostia, ES)
Doctor M. Lisiak (Wroclaw, PL)
Mrs M. Faraudo (Sant Joan Despi (Barcelona), ES)
Doctor C. Goena Vives (Donostia, ES)
Access the full session
The Event
Heart Failure 2026
10 May 2026
08:30 CET
You may be interested in
Congress Session
Congress Session
